Company · CIK 2088082

# Electra Therapeutics, Inc.

| CIK | [2088082](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002088082) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | ETRA (Nasdaq) |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-298617 | IPO Final prospectus | 2026-08-28 | 2026-09-18 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-18 | [424B4](https://www.sec.gov/Archives/edgar/data/2088082/000119312526395670/0001193125-26-395670-index.htm) Final prospectus | 333-298617 | 0001193125-26-395670 |
| 2026-09-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2088082/999999999526002994/9999999995-26-002994-index.htm) Declared effective | 333-298617 | 9999999995-26-002994 |
| 2026-09-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2088082/000119312526389755/0001193125-26-389755-index.htm) Amendment | 333-298617 | 0001193125-26-389755 |
| 2026-08-28 | [S-1](https://www.sec.gov/Archives/edgar/data/2088082/000119312526374259/0001193125-26-374259-index.htm) Registration filed | 333-298617 | 0001193125-26-374259 |
| 2026-06-26 | [DRS](https://www.sec.gov/Archives/edgar/data/2088082/000119312526285726/0001193125-26-285726-index.htm) Draft made public | 377-09513 | 0001193125-26-285726 |

[All filings of this company](https://equitycapital.markets/filings?cik=2088082) · [CSV](https://equitycapital.markets/filings.csv?cik=2088082)

---
Source page: https://equitycapital.markets/company/2088082 · Data: U.S. SEC EDGAR · CC BY 4.0